These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 590342)

  • 1. Effect of intracerebroventricular administration of morphine upon intestinal motility in rat and its antagonism with naloxone.
    Parolaro D; Sala M; Gori E
    Eur J Pharmacol; 1977 Dec; 46(4):329-38. PubMed ID: 590342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral components of dermorphin's effect on rat intestinal propulsion in comparison to morphine.
    Parolaro D; Sala M; Crema G; Spazzi L; Cesana R; Gori E
    Peptides; 1983; 4(1):55-8. PubMed ID: 6866810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on intestinal transit of neurotensin administered intracerebroventricularly to rats.
    Parolaro D; Sala M; Crema G; Spazzi L; Gori E
    Life Sci; 1983; 33 Suppl 1():485-8. PubMed ID: 6664230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrally mediated inhibition of small intestinal transit and motility by morphine in the rat.
    Galligan JJ; Burks TF
    J Pharmacol Exp Ther; 1983 Aug; 226(2):356-61. PubMed ID: 6875849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central and peripheral inhibitory effects of morphine on intestinal transit in mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1986 Aug; 8(8):479-83. PubMed ID: 3747641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central and peripheral inhibition of gastrointestinal transit in rats: narcotics differ substantially by acting at either or both levels.
    Peracchia F; Bianchi G; Fiocchi R; Petrillo P; Tavani A; Manara L
    J Pharm Pharmacol; 1984 Oct; 36(10):699-701. PubMed ID: 6150093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further investigations on neurotensin as central modulator of intestinal motility in rats.
    Parolaro D; Sala M; Patrini G; Biffi E; Pecora N; Gori E
    Regul Pept; 1987 Feb; 17(2):111-7. PubMed ID: 3107088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipropulsive effects of central and peripheral morphine in the rat gastrointestinal tract.
    Stewart JJ; Curd CD
    J Pharm Pharmacol; 1984 Jul; 36(7):476-7. PubMed ID: 6146697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of the effects of centrally-administered morphine on colonic motility in dogs by the benzodiazepine receptor antagonist RO 15-1788.
    Fioramonti J; Fargeas MJ; Buéno L
    Life Sci; 1987 Sep; 41(12):1449-55. PubMed ID: 3041141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats.
    Gmerek DE; Cowan A; Woods JH
    J Pharmacol Exp Ther; 1986 Jan; 236(1):8-13. PubMed ID: 3941402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis toxin modifies the effect of central morphine on rat intestinal motility.
    Parolaro D; Patrini G; Massi P; Parenti M; Rubino T; Giagnoni G; Gori E
    Eur J Pharmacol; 1990 Feb; 177(1-2):75-80. PubMed ID: 2160368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites.
    Manara L; Bianchi G; Ferretti P; Tavani A
    J Pharmacol Exp Ther; 1986 Jun; 237(3):945-9. PubMed ID: 3012075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different targets for i.v. vs. i.c.v. administered morphine for its effect on colonic motility in dogs.
    Fioramonti J; Fargeas MJ; Bueno L
    Eur J Pharmacol; 1985 Oct; 117(1):115-20. PubMed ID: 4085540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine as a central modulator of rat intestinal transit.
    Parolaro D; Patrini G; Massi P; Mainardi P; Giagnoni G; Sala M; Gori E
    J Pharmacol Exp Ther; 1989 Apr; 249(1):324-8. PubMed ID: 2565394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for serotonergic system involvement in the effect of morphine on gastrointestinal motility in the rat.
    Pourgholami MH; Goshadrou F
    Gen Pharmacol; 1995 Jul; 26(4):779-83. PubMed ID: 7635252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestine.
    Bianchi G; Fiocchi R; Peracchia F; Petrillo P; Tavani A; Manara L
    J Pharm Pharmacol; 1984 May; 36(5):326-30. PubMed ID: 6145770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on the antagonism of the intestinal inhibitory effects of morphine and clonidine by yohimbine in mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1986 Dec; 8(12):715-9. PubMed ID: 3027469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of antagonism of morphine antinociception by intracerebroventricularly administered naloxone in the rat.
    Porreca F; Cowan A; Tallarida RJ
    Eur J Pharmacol; 1981 Nov; 76(1):55-9. PubMed ID: 7318922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of prolyl-leucyl-glycinamide and naloxone on morphine-induced inhibition of gastrointestinal transit.
    Pillai NP; Bhargava HN
    Pharmacol Biochem Behav; 1984 Sep; 21(3):365-8. PubMed ID: 6149566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further investigations on the antipropulsive effect of centrally administered histamine and its relation with morphine.
    Patrini G; Massi P; Rubino T; Donin L; Gori E; Parolaro D
    Eur J Pharmacol; 1992 Jan; 210(3):259-64. PubMed ID: 1612102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.